← Eichor
Study identifier: NCT05361603 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures

Condition: Hepatitis C · Transmission, Intravenous Drug Abuser · Addiction, Alcohol  ·  Sponsor: University Hospital, Limoges

PhaseN/A
Planned participants1500
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

The principle is to propose dedicated monthly screening days bringing together the health personnel involved (hepatologist, addictologist, nurse in charge of the program, addictology nurse and social worker) and to propose appropriate management for each situation assessed.

This description comes directly from the study's public registry record.

Talk to the study team

Marilyne DEBETTE-GRATIEN, MD  ·  33 5 55 05 87 26  ·  MARILYNE.GRATIEN@chu-limoges.fr

Véronique LOUSTAUD-RATTI, Prof  ·  33 5 55 05 66 84  ·  veronique.loustaud-ratti@unilim.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Chu LimogesLimoges, Haute Vienne, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05361603